SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: silInv who wrote (907)4/20/1999 4:32:00 PM
From: Platter  Respond to of 965
 
From Briefing.com..another upgrade..Centocor Inc. (CNTO) : BancBoston Robertson Stephens upgrades biopharmaceutical company from long-term "attractive" to "strong buy" on view that Remicade sales, its Crohn's disease treatment, will grow sequentially; sets a 12-month price target of $55......




To: silInv who wrote (907)4/21/1999 12:55:00 PM
From: Ibexx  Read Replies (2) | Respond to of 965
 
Where is everybody? Stock is up more than $5!

A delayed response to the super strong earnings momentum.

Ibexx